Release Date: 01/05/17 08:04 Summary: Quarterly Activities and Cash Flow Report to 31 March 2017 Price Sensitive: Yes Download Document 1.03MB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status